OSE免疫治疗公司(OSE Immunotherapeutics,OSE)宣布已任命马克·勒博泽克(Marc Le Bozec)为临时首席执行官,接替尼古拉斯·普瓦里耶(Nicolas Poirier)。这一领导层变动正值公司寻求加强其战略方向和运营效率之际。

本文地址: http://www.jiaotongmi.com/article/13756.html
文章来源:admin
版权声明:除非特别标注,否则均为本站原创文章,转载时请以链接形式注明文章出处。
2025-11-19admin
2025-11-13admin
2025-11-12admin
2025-11-11admin
2025-11-10admin
2025-11-09admin
2025-11-08admin
2025-11-07admin
2025-11-06admin
2025-11-05admin
2025-09-08admin
2025-09-08admin
2025-09-17admin
2025-09-17admin
2025-09-13admin
2025-09-08admin
2025-09-09admin
2025-09-09admin
2025-09-13admin
2025-09-11admin
2025-10-15admin
2025-10-14admin
2025-10-15admin
2025-10-16admin
2025-10-15admin
2025-10-16admin
2025-10-14admin
2025-10-14admin
2025-10-14admin
2025-10-15admin
扫码二维码
获取最新动态
